Colon-specific delivery of mesalazine chitosan microspheres

Journal of Microencapsulation

Volumn 23, Issue 3, 2006, Pages 329-339

  Varshosaz, J ^a   Jaffarian Dehkordi, A ^a   Golafshan, S ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chitosan; Colon delivery; Mesalazine; Microsphere

Indexed keywords

ACETIC ACID; ANTIINFLAMMATORY AGENT; CHITOSAN; MESALAZINE; MICROSPHERE; PROSTAGLANDIN SYNTHASE INHIBITOR; SOLVENT;

ADHESION; AQUEOUS SOLUTION; ARTICLE; CECUM; COLON; CONTROLLED STUDY; DISPERSION; DRUG DELIVERY SYSTEM; DRUG RELEASE; EMULSION; EVAPORATION; IN VITRO STUDY; INTESTINE SECRETION; MATERIAL COATING; MOLECULAR WEIGHT; NONHUMAN; PARTICLE SIZE; PH MEASUREMENT; RAT; STATISTICAL SIGNIFICANCE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHITOSAN; COLON; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; MALE; MESALAMINE; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; MOLECULAR WEIGHT; RATS; RATS, WISTAR;

EID: 33745521414     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.1080/02652040600612405     Document Type: Article

References (41)

1. Agnihotri, AS and Aminabhavi, TM. (2004) Formulation and evaluation of novel tableted chitosan microparticles for the controlled release of clozapine Journal of Microencapsulation, 21, pp. 709-718.
2. Arnaud, P and Boué, C and Chaumeil, JC. (1996) Cellulose acetate butyrate microparticles for controlled release of carbamazepine Journal of Microencapsulation, 13, pp. 407-417.
3. Berthold, A and Cremer, K and Kreuter, J. (1996) Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs Journal of Controlled Release, 39, pp. 17-25.
4. Bussemer, T and Otto, I and Bodmeier, R. (2001) Pulsatile drug-delivery systems Drug Carrier Systems, 18, pp. 433-458.
5. Chae, SY and Jang, MK and Nah, JW. (2005) Influence of molecular weight on oral absorption of water soluble chitosans Journal of Controlled Release, 102, pp. 383-394.
6. Costa, P and Manuel, J and Lobo, S. (2001) Modeling and comparison of dissolution profiles European Journal of Pharmaceutical Sciences, 13, pp. 123-133.
7. Deasy, PB. (1984) Microencapsulation and related drug process. New York: Marcel Dekker.
8. Genta, I and Perugini, P and Conti, B and Pavanetto, F. (1997) A multiple emulsion method to entrap a lipophilic compound into chitosan microspheres International Journal of Pharmaceutics, 152, pp. 237-246.
9. Genta, I and Perugini, P and Pavanetto, F. (1998) Different molecular weight chitosan microspheres: Influence on drug loading and drug release Drug Development and Industrial Pharmacy, 24, pp. 779-784.
10. 2 factorial design Drug Development and Industrial Pharmacy, 28, pp. 77-87.
11. Gorbach, SL. (1971) Intestinal flora Gastroenterology, 60, pp. 1110-1129.
12. He, P and Davis, SS and Illum, L. (1998) In vitro evaluation of the mucoadhesive properties of chitosan microspheres International Journal of Pharmaceutics, 166, pp. 68-75.
13. He, P and Davis, SS and Illum, L. (1999a) Chitosan microspheres prepared by spray drying International Journal of Pharmaceutics, 187, pp. 53-65.
14. He, P and Davis, SS and Illum, L. (1999b) Sustained release chitosan microspheres prepared by spray drying methods Journal of Microencapsulation, 16, pp. 343-355.
15. Ikinci, G and Şenel, S and Akincibay, H and Kaş, S and Erciş, S and Wilson, CG and Hincal, AA. (2002) Effect of chitosan on a periodontal pathogen Porphyromonas gingivalis International Journal of Pharmaceutics, 235, pp. 121-127.
16. Illum, L and Farraj, NF and Davis, SS. (1994) Chitosan as a novel nasal delivery system for peptide drugs Pharmaceutical Research, 11, pp. 1186-1189.
17. Kas, HS. (1997) Chitosan: Properties, preparation and application to microparticulate systems Journal of Microencapsulation, 14, pp. 689-711.
18. Krishnaiah, YSR and Seetha, DA and Nageswara, RL and Bhaskar, RPR and Karthikeyan, RS and Satyanargana, V. (2001) Guar gum as a carrier for colon specific delivery; influences of metronidazol and tinidazol on in vitro release of albendazol from guar gum matrix tablets Journal of Pharmacy and Pharmaceutical Science, 4, pp. 235-243.
19. Kweon, DK and Kang, DW. (1999) Drug release behavior of chitosan-gpoly (vinyl alcohol) copolymer matrix Journal of Applied Polymer Science, 74, pp. 458-464.
20. Lorenso-Lomasa, ML and Remunan-Lopez, C and Vila-Jato, JL and Alonso, MJ. (1998) Design of microencapsulated chitosan microspheres for colonic drug delivery Journal of Controlled Release, 52, pp. 109-118.
21. Luessen, HL and de Leeuw, BJ and Langemeyer, MWE and de Boer, AB and Verhoef, JC and Junginger, HE. (1996) Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug Buserelin in vitro Pharmaceutical Research, 12, pp. 1668-1672.
22. Macfarlane, GT and Cummings, JH. (1991) The colonic flora, fermentation, and large bowel digestive function. In The large intestine: Physiology, pathophysiology, and diseases. (pp. 51-92). New York: Raven Press.
23. Mathiowitz, E and Chickering III, D and Lehr, C. (1999) Bioadhesive drug delivery systems, fundamentals, novel approaches, and development. New York: Marcel Dekker.
24. Miyazaki, Y and Ogihara, K and Yakou, S and Nagai, T and Takayama, K. (2003) In vitro and in vivo evaluation of mucoadhesive microspheres consisting of dextran derivatives and CAB International Journal of Pharmaceutics, 258, pp. 21-29.
25. Onishi, H and Machida, Y. (1999) Biodegradation and distribution of water-soluble chitosan in mice Biomaterials, 20, pp. 175-182.
26. Peppercorn, MA. (1992) The medical therapy of ulcerative colitis and Crohn's disease. In Inflammatory bowel disease. (pp. 555-577). New York: Elsevier Science Publishing.
27. Pongpaibul, Y and Wilworth, CW. (1986) Preparation and in vitro dissolution characteristics of propranolol microcapsules International Journal of Pharmaceutics, 33, pp. 243-248.
28. Ramesh, HP and Viswanatha, S and Tharanathan, RN. (2004) Safety evaluation of formulations containing carboxymethyl derivatives of starch and chitosan in albino rats Carbohydrate Polymers, 58, pp. 435-441.
29. Remunan-Lopez, C and Lorenzo-Lamosa, ML and Vila-Jato, JL and Alonso, MJ. (1998) Development of new chitosan-cellulose multicore microparticles for controlled drug delivery European Journal of Pharmaceutics and Biopharmaceutics, 45, pp. 49-56.
30. Rijk, MCM and Schaik, AV and Tongeren, JHMV. (1988) Disposition of 5-aminosalicylic acid by 5-aminosalicylic acid-delivering compounds Scandinavian Journal of Gastroenterology, 23, pp. 107-112.
31. Ruiz, R and Sark, A and Sprockel, OL. (1990) A study on the manufacture and in vitro dissolution of terbutaline sulfate microcapsules Drug Development and Industrial Pharmacy, 16, pp. 1829-1842.
32. Shareef, MA and Khar, RK and Ahuja, A and Ahmad, FJ and Raghava, S. (2003) Colonic drug delivery: An updated review AAPS Pharmaceutical Science, 5, pp. 4.
33. Sprockel, OL and Prapaitrakul, W. (1990) A comparison of microencapsulation by various emulsion techniques International Journal of Pharmaceutics, 58, pp. 123-127.
34. Tefft, J and Friend, DR. (1993) Controlled release of herbicide formulations based on polymeric microsphers Journal of Controlled Release, 27, pp. 27-35.
35. Vandamme, ThF and Lenourry, A and Charrueav, C and Chaumeil, JC. (2002) The use of polysaccharides to target drugs at the colon Carbohyrate Polymers, 48, pp. 219-231.
36. Vasir, JK and Tambwelear, K and Garg, S. (2003) Bioadhesive microspheres as a controlled drug delivery system International Journal of Pharmaceutics, 255, pp. 13-32.
37. Vos, MD and Verdievel, H and Schoonjans, R and Praet, M and Bogaert, M and Barbier, F. (1992) Concentrations of 5-ASA and Ac-5-ASA in human ileocolonic biopsy homogenates after oral 5-ASA preparations Gut, 33, pp. 1338-1342.
38. Wu, CS. (2005) A comparison of the structure, thermal properties, and biodegradability of polycaprolactone/chitosan and acrylic acid grafted polycaprolactone/chitosan Polymer, 46, pp. 147-155.
39. Yamamoto, A and Tozaki, H and Okada, N and Fujita, T. (2000) Colon specific delivery of peptide drugs and anti-inflammatory drugs using chitosan capsules. S.T.P Pharma Sciences, 10, pp. 23-43.
40. Yang, L and Chu, JS and Fix, JA. (2002) Colon-specific drug delivery, new approaches. An in-vivo, in-vitro evaluation International Journal of Pharmaceutics, 235, pp. 1-15.
41. Zahirul, M and Khan, I and Prebey, E and Kurjakovi, NA. (1999) PH-dependent colon polymers Journal of Controlled Release, 58, pp. 215-222.